Table of Content


Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing the Study
1.3 What’s New in This Update?
1.4 Scope of Report
1.5 Intended Audience
1.6 Research Methodology
1.7 Geographic Breakdown
1.8 Analyst’s Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Overview
3.1 Introduction
3.2 Historical Perspective
3.3 Definitions
3.3.1 Genomics
3.3.2 Proteomics
3.3.3 Epigenomics
3.3.4 Sample Preparation
3.3.5 Molecular Biology
3.3.6 DNA Structure
3.3.7 DNA Replication
3.3.8 Proteins
3.4 Central Principles
3.5 Genomics
3.5.1 Comparative Genomics
3.5.2 Functional Genomics
3.5.3 Structural Genomics
3.6 Proteomics
3.6.1 Expression Proteomics
3.6.2 Structural Proteomics
3.6.3 Functional Proteomics
3.7 Epigenomics
3.8 Trends in R&D
3.8.1 Global Spending on R&D
3.8.2 Increase in R&D Spending on Healthcare
3.8.3 China: A Rising Hub for Science and Technology
3.8.4 R&D Funding
3.8.5 Global Increase in the Number of Researchers
3.9 Market Dynamics
3.9.1 Drivers
3.9.2 Restraints
3.9.3 Opportunities
3.9.4 Challenges
3.9.5 Limitations of Sample Preparation
Chapter 4 Impact of COVID-19 Pandemic
Chapter 5 Market Breakdown by Product Segment
5.1 Instruments
5.1.1 Global Market for Instruments by Type
5.1.2 Regional Markets for Instruments
5.1.3 Instrument Market Subsegments
5.2 Consumables
5.2.1 Regional Markets for Consumables
5.2.2 Market for Consumables by Product Type
5.3 Accessories
5.3.1 Regional Markets for Accessories
5.4 Sample Preparation Kits
5.4.1 Regional Markets for Sample Preparation Kits
5.4.2 Market for Sample Preparation Kits by Product Segment
Chapter 6 Market Breakdown by Application Segment
6.1 Genomics Applications
6.1.1 Medicine
6.1.2 Agriculture
6.2 Proteomics Applications
6.2.1 Oncology
6.2.2 Biomedical
6.2.3 Agriculture
6.2.4 Food Microbiology
6.3 Epigenomics Applications
Chapter 7 Market Breakdown by End User
7.1 Research Centers, Academic Institutes, and Government Agencies
7.2 Hospitals and Clinics
7.3 Pharmaceutical and Biotechnology Companies
7.4 Others
Chapter 8 Market Breakdown by Region
8.1 North America
8.1.1 National Institutes of Health
8.1.2 Decreasing R&D Spending
8.1.3 Growing Genetic Testing Market
8.1.4 Genetically Modified Crops
8.1.5 Government and Private Initiatives
8.1.6 Drug Discovery Driving the Market for Proteomics
8.1.7 Canada
8.1.8 Epigenomics
8.2 Europe
8.2.1 European 1+ Million Genome Initiative
8.2.2 Public Health Genomics European Network (PHGEN)
8.2.3 $3.4 Million Investment into Three-Dimensional Genomics
8.2.4 United Kingdom
8.2.5 U.K. 100,000 Genomes Project
8.2.6 Impact of Brexit
8.2.7 France
8.2.8 Germany
8.2.9 Rest of the Europe
8.2.10 New International Genome Research Centre in Denmark
8.3 Asia-Pacific
8.3.1 Genome Asia-Pacific 100K Initiative
8.3.2 Asia-Pacific: A New Hub for R&D
8.3.3 Global Collaboration Required
8.3.4 Australia
8.3.5 China
8.3.6 China Leading Asia-Pacific and Positioned to Lead World Genomics
8.3.7 Japan
8.3.8 Rest of Asia
8.3.9 Rest of the World
8.3.10 Middle East
8.3.11 Latin American Countries
Chapter 9 Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
DANAHER CORP.
HAMILTON CO.
ILLUMINA INC.
MERCK MILLIPORE
NORGEN BIOTEK CORP.
PERKINELMER INC.
PRESSURE BIOSCIENCES INC.
PROMEGA CORP.
QIAGEN GMBH
ROCHE
TECAN GROUP LTD.
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.
Chapter 10 Competitive Landscape
Chapter 11 Appendix: List of Acronyms



List of Figures

Summary Figure : Global Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, 2019-2027
Figure 1 : Global Spending on Research and Development in 1960 and 2020 and the Role of the U.S.
Figure 2 : Market Dynamics of Genomics, Proteomics, and Epigenomics Sample Preparation
Figure 3 : Comparison of Cost Distribution of Next-Generation Sequencing: Past, Present
Figure 4 : Impact of COVID-19 on the Market
Figure 5 : Different Application of Genomics
Figure 6 : Various Application of Proteomics
Figure 7 : Average New Genetic Testing Units Per Day
Figure 8 : Agilent Technologies Inc.: Revenue Share, by Segment, 2021
Figure 9 : Agilent Technologies Inc.: Revenue Share, by Product and Services
Figure 10 : Bio-Rad Laboratories Inc.: Revenue Share, by Segment, 2021
Figure 11 : Danaher Corp.: Revenue Share, by Segment
Figure 12 : Illumina Inc.: Revenue Share, by Segment, 2021
Figure 13 : Illumina Inc.: Revenue Share, by Region 2021
Figure 14 : Merck Millipore: Revenue Share, by Regional Life Science Segment
Figure 15 : PerkinElmer Inc.: Revenue Share, by Segment, 2021
Figure 16 : PerkinElmer Inc.: Revenue Share, by Region, 2021
Figure 17 : PerkinElmer Inc.: Revenue Share, by Products and Services, 2021
Figure 18 : Pressure Biosciences Inc.: Revenue Share, by Segment
Figure 19 : Qiagen GmbH: Revenue Share, by Region
Figure 20 : Qiagen GmbH: Revenue Share, by Consumables and Instruments
Figure 21 : Qiagen GmbH: Revenue Share, by Segment
Figure 22 : Roche: Revenue Share, by Segment
Figure 23 : Roche: Revenue Share, by Region
Figure 24 : Tecan Group Ltd.: Revenue Share, by Segment
Figure 25 : Tecan Group Ltd.: Revenue Share, by Region
Figure 26 : Thermo Fisher Scientific Inc.: Revenue Share, by Segment, 2021
Figure 27 : Waters Corp.: Revenue Share, by Product and Services
Figure 28 : Waters Corp.: Revenue Share, by Region, 2021
Figure 29 : Waters Corp.: Revenue Share, by End User, 2021
Figure 30 : Waters Corp.: Revenue Share, by Products and Services, 2021
Figure 31 : Market Share Analysis of Sample Preparation Market for Genomics, Proteomics, and Epigenomics

List of Tables

Summary Table : Global Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 1 : Timeline of Important Discoveries in the Field of Genomics, 1865-2003
Table 2 : Nitrogen Base in DNA
Table 3 : Enzymes Used in DNA Replication
Table 4 : Essential and Nonessential Amino Acids
Table 5 : Genome Sizes of Model Systems
Table 6 : Differences Between Genomics and Proteomics
Table 7 : R&D Expenditure in the Year 2020, by Country
Table 8 : Various Variants of CORONA Virus and Their Sample Documented Timeline
Table 9 : Global Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 10 : Global Market for Instruments Used in Sample Preparation in Genomics, Proteomics, and Epigenomics, by Region, Through 2027
Table 11 : Global Market for Consumables Used in Sample Preparation in Genomics, Proteomics, and Epigenomics, by Region, Through 2027
Table 12 : Global Market for Consumables Used in Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type, Through 2027
Table 13 : Global Market for Accessories Used in Sample Preparation in Genomics, Proteomics, and Epigenomics, by Region, Through 2027
Table 14 : Sample Preparation Kits, by Company
Table 15 : Number of Publications Citing Each Type of Main DNA Extraction and Purification Kits Offered by Each of the Major Suppliers, April 1, 2015
Table 16 : Global Market for Sample Preparation Kits Used in Genomics, Proteomics, and Epigenomics, by Region, Through 2027
Table 17 : Global Market for Sample Preparation Kits Used in Genomics, Proteomics, and Epigenomics, by Type, Through 2024
Table 18 : Overview of DNA Purification Kits for PCR Products and Enzymatic Reactions
Table 19 : Overview of DNA Extraction and Purification Kits for Microbes
Table 20 : Overview of Extraction and Purification DNA Kits for Animal Tissue and Cells
Table 21 : Overview of DNA Extraction and Purification Kits for Plant Tissue and Cells
Table 22 : Overview of DNA Extraction and Purification Kits for Animal Tissue and Cells and Microbes
Table 23 : Overview of DNA Extraction and Purification Kits for Samples From Animal, Microbial, and Plant Origin
Table 24 : Global Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Application Segment, Through 2027
Table 25 : The Four Drug Metabolism Phenotypes
Table 26 : Global Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by End User, Through 2027
Table 27 : Global Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Region, Through 2027
Table 28 : North American Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Country, Through 2027
Table 29 : Direct-To-Consumer Genetic Tests
Table 30 : Summary of the FDA’s Inventory of Completed Biotechnology Consultations on Genetically Engineered Foods, June 30, 2015
Table 31 : U.S. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 32 : U.S. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 33 : U.S. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 34 : U.S. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 35 : Canadian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 36 : Canadian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 37 : Canadian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 38 : Canadian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 39 : Gross Domestic Expenditures on R&D, by Country, 2020
Table 40 : European Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Country/Region, Through 2027
Table 41 : U.K. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 42 : U.K. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 43 : U.K. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 44 : U.K. Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 45 : French Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 46 : French Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 47 : French Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 48 : French Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 49 : German Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 50 : German Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 51 : German Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 52 : German Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 53 : Rest of Europe Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 54 : Rest of Europe Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 55 : Rest of Europe Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 56 : Rest of Europe Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 57 : Asia-Pacific Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Country/Region, Through 2027
Table 58 : East Asia-Pacific Centers and Resources for Human Genomic Research, by Country
Table 59 : ELSI Practices and Regulation of Human Genomic Research in East Asia-Pacific, by Country
Table 60 : Australian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 61 : Australian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 62 : Australian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 63 : Australian Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 64 : Flagship Genomics Projects, Australia
Table 65 : Chinese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 66 : Chinese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 67 : Chinese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 68 : Chinese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 69 : Japanese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 70 : Japanese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 71 : Japanese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 72 : Japanese Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 73 : Rest of Asia Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 74 : Rest of Asia Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 75 : Rest of Asia Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 76 : Rest of Asia Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 77 : Rest of the World Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Product Segment, Through 2027
Table 78 : Rest of the World Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Instrument, Through 2027
Table 79 : Rest of the World Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Consumable, Through 2027
Table 80 : Rest of the World Market for Sample Preparation in Genomics, Proteomics, and Epigenomics, by Type of Kit, Through 2027
Table 81 : Genetic Disorders Under Brazilian Federal Clinical Protocols and Guidelines for Treatment Including Newborn Screening
Table 82 : Agilent: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 83 : Agilent Technologies Inc.: Revenue and R&D Expenditures, 2019-2021
Table 84 : Agilent Technologies Inc.: Developments, 2019-2021
Table 85 : Bio-Rad Laboratories Inc.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 86 : Bio-Rad Laboratories Inc.: Revenue and R&D Expenditures, 2019-2021
Table 87 : Bio-Rad Laboratories Inc.: Developments, 2022
Table 88 : Danaher: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 89 : Danaher Corp.: Revenue and R&D Expenditures, 2019-2021
Table 90 : Danaher Corp.: Developments, 2019-2021
Table 91 : Hamilton: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 92 : Illumina Inc.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 93 : Illumina Inc.: Revenue and R&D Expenditures, 2019-2021
Table 94 : Illumina Inc.: Developments, 2021 and 2022
Table 95 : Merck Millipore: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 96 : Merck Millipore: Revenue and R&D Expenditures, 2019-2021
Table 97 : Merck Millipore: Revenue, Life Science Segment, 2019-2021
Table 98 : Merck MIllipore.: Developments, 2020 and 2021
Table 99 : Norgen Biotek Corp.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 100 : Norgen Biotek Corp.: Developments, 2018
Table 101 : PerkinElmer Inc.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 102 : PerkinElmer Inc.: Revenue and R&D Expenditures, 2019-2021
Table 103 : PerkinElmer Inc.: Developments, 2021 and 2022
Table 104 : Pressure BioSciences Inc.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 105 : Pressure BioSciences Inc.: Revenue and R&D Expenditures, 2016-2018
Table 106 : Promega Corp.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 107 : Qiagen GmbH: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 108 : Qiagen GmbH: Revenue and R&D Expenditures, 2019-2021
Table 109 : Qiagen GmbH: Developments, 2020 and 2021
Table 110 : Roche: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 111 : Roche: Revenue and R&D Expenditures, 2019-2021
Table 112 : Tecan Group Ltd.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 113 : Tecan Group Ltd.: Revenue and R&D Expenditures, 2019-2021
Table 114 : Tecan Group Ltd.: Developments, 2019-2022
Table 115 : Thermo Fisher Scientific Inc.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 116 : Thermo Fisher Scientific Inc.: Revenue and R&D Expenditures, 2019-2021
Table 117 : Waters Corp.: Products for Genomics, Proteomics, and Epigenomics Sample Preparation
Table 118 : Waters Corp.: Revenue and R&D Expenditures, 2019-2021
Table 119 : Waters Corp.: Developments, 2022
Table 120 : Various Development Strategies in Sample Preparation in Genomics, Proteomics, and Epigenomics Market
Table 121 : List of Acronyms Used in This Report